Copyright Reports & Markets. All rights reserved.

Global Insulin Like Growth Factor 1 Receptor Market Professional Survey Report 2019

Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Insulin Like Growth Factor 1 Receptor

      • 1.1 Definition of Insulin Like Growth Factor 1 Receptor
      • 1.2 Insulin Like Growth Factor 1 Receptor Segment by Type
        • 1.2.1 Global Insulin Like Growth Factor 1 Receptor Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 BI-893923
        • 1.2.3 CT-707
        • 1.2.4 1R-E1
        • 1.2.5 ATL-1101
        • 1.2.6 Others
      • 1.3 Insulin Like Growth Factor 1 Receptor Segment by Applications
        • 1.3.1 Global Insulin Like Growth Factor 1 Receptor Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Hospital
        • 1.3.3 Clinic
        • 1.3.4 Others
      • 1.4 Global Insulin Like Growth Factor 1 Receptor Overall Market
        • 1.4.1 Global Insulin Like Growth Factor 1 Receptor Revenue (2014-2025)
        • 1.4.2 Global Insulin Like Growth Factor 1 Receptor Production (2014-2025)
        • 1.4.3 North America Insulin Like Growth Factor 1 Receptor Status and Prospect (2014-2025)
        • 1.4.4 Europe Insulin Like Growth Factor 1 Receptor Status and Prospect (2014-2025)
        • 1.4.5 China Insulin Like Growth Factor 1 Receptor Status and Prospect (2014-2025)
        • 1.4.6 Japan Insulin Like Growth Factor 1 Receptor Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Insulin Like Growth Factor 1 Receptor Status and Prospect (2014-2025)
        • 1.4.8 India Insulin Like Growth Factor 1 Receptor Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Insulin Like Growth Factor 1 Receptor
      • 2.3 Manufacturing Process Analysis of Insulin Like Growth Factor 1 Receptor
      • 2.4 Industry Chain Structure of Insulin Like Growth Factor 1 Receptor

      3 Development and Manufacturing Plants Analysis of Insulin Like Growth Factor 1 Receptor

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Insulin Like Growth Factor 1 Receptor Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Insulin Like Growth Factor 1 Receptor
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Insulin Like Growth Factor 1 Receptor Production and Capacity Analysis
      • 4.2 Insulin Like Growth Factor 1 Receptor Revenue Analysis
      • 4.3 Insulin Like Growth Factor 1 Receptor Price Analysis
      • 4.4 Market Concentration Degree

      5 Insulin Like Growth Factor 1 Receptor Regional Market Analysis

      • 5.1 Insulin Like Growth Factor 1 Receptor Production by Regions
        • 5.1.1 Global Insulin Like Growth Factor 1 Receptor Production by Regions
        • 5.1.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Regions
      • 5.2 Insulin Like Growth Factor 1 Receptor Consumption by Regions
      • 5.3 North America Insulin Like Growth Factor 1 Receptor Market Analysis
        • 5.3.1 North America Insulin Like Growth Factor 1 Receptor Production
        • 5.3.2 North America Insulin Like Growth Factor 1 Receptor Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Insulin Like Growth Factor 1 Receptor Import and Export
      • 5.4 Europe Insulin Like Growth Factor 1 Receptor Market Analysis
        • 5.4.1 Europe Insulin Like Growth Factor 1 Receptor Production
        • 5.4.2 Europe Insulin Like Growth Factor 1 Receptor Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Insulin Like Growth Factor 1 Receptor Import and Export
      • 5.5 China Insulin Like Growth Factor 1 Receptor Market Analysis
        • 5.5.1 China Insulin Like Growth Factor 1 Receptor Production
        • 5.5.2 China Insulin Like Growth Factor 1 Receptor Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Insulin Like Growth Factor 1 Receptor Import and Export
      • 5.6 Japan Insulin Like Growth Factor 1 Receptor Market Analysis
        • 5.6.1 Japan Insulin Like Growth Factor 1 Receptor Production
        • 5.6.2 Japan Insulin Like Growth Factor 1 Receptor Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Insulin Like Growth Factor 1 Receptor Import and Export
      • 5.7 Southeast Asia Insulin Like Growth Factor 1 Receptor Market Analysis
        • 5.7.1 Southeast Asia Insulin Like Growth Factor 1 Receptor Production
        • 5.7.2 Southeast Asia Insulin Like Growth Factor 1 Receptor Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Insulin Like Growth Factor 1 Receptor Import and Export
      • 5.8 India Insulin Like Growth Factor 1 Receptor Market Analysis
        • 5.8.1 India Insulin Like Growth Factor 1 Receptor Production
        • 5.8.2 India Insulin Like Growth Factor 1 Receptor Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Insulin Like Growth Factor 1 Receptor Import and Export

      6 Insulin Like Growth Factor 1 Receptor Segment Market Analysis (by Type)

      • 6.1 Global Insulin Like Growth Factor 1 Receptor Production by Type
      • 6.2 Global Insulin Like Growth Factor 1 Receptor Revenue by Type
      • 6.3 Insulin Like Growth Factor 1 Receptor Price by Type

      7 Insulin Like Growth Factor 1 Receptor Segment Market Analysis (by Application)

      • 7.1 Global Insulin Like Growth Factor 1 Receptor Consumption by Application
      • 7.2 Global Insulin Like Growth Factor 1 Receptor Consumption Market Share by Application (2014-2019)

      8 Insulin Like Growth Factor 1 Receptor Major Manufacturers Analysis

      • 8.1 Astellas Pharma Inc.
        • 8.1.1 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
        • 8.1.2 Astellas Pharma Inc. Product Introduction, Application and Specification
        • 8.1.3 Astellas Pharma Inc. Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 AstraZeneca Plc
        • 8.2.1 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
        • 8.2.2 AstraZeneca Plc Product Introduction, Application and Specification
        • 8.2.3 AstraZeneca Plc Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Axelar AB
        • 8.3.1 Axelar AB Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
        • 8.3.2 Axelar AB Product Introduction, Application and Specification
        • 8.3.3 Axelar AB Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 Boehringer Ingelheim GmbH
        • 8.4.1 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
        • 8.4.2 Boehringer Ingelheim GmbH Product Introduction, Application and Specification
        • 8.4.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Bristol-Myers Squibb Company
        • 8.5.1 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
        • 8.5.2 Bristol-Myers Squibb Company Product Introduction, Application and Specification
        • 8.5.3 Bristol-Myers Squibb Company Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Eli Lilly and Company
        • 8.6.1 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
        • 8.6.2 Eli Lilly and Company Product Introduction, Application and Specification
        • 8.6.3 Eli Lilly and Company Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 F. Hoffmann-La Roche Ltd.
        • 8.7.1 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
        • 8.7.2 F. Hoffmann-La Roche Ltd. Product Introduction, Application and Specification
        • 8.7.3 F. Hoffmann-La Roche Ltd. Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 Genmab A/S
        • 8.8.1 Genmab A/S Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
        • 8.8.2 Genmab A/S Product Introduction, Application and Specification
        • 8.8.3 Genmab A/S Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Immunomedics, Inc.
        • 8.9.1 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
        • 8.9.2 Immunomedics, Inc. Product Introduction, Application and Specification
        • 8.9.3 Immunomedics, Inc. Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Insmed Incorporated
        • 8.10.1 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Production Sites and Area Served
        • 8.10.2 Insmed Incorporated Product Introduction, Application and Specification
        • 8.10.3 Insmed Incorporated Insulin Like Growth Factor 1 Receptor Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 Merck & Co., Inc.
      • 8.12 Merrimack Pharmaceuticals, Inc.
      • 8.13 Novartis AG
      • 8.14 PharmAbcine, Inc.
      • 8.15 ProteoThera, Inc.

      9 Development Trend of Analysis of Insulin Like Growth Factor 1 Receptor Market

      • 9.1 Global Insulin Like Growth Factor 1 Receptor Market Trend Analysis
        • 9.1.1 Global Insulin Like Growth Factor 1 Receptor Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Insulin Like Growth Factor 1 Receptor Regional Market Trend
        • 9.2.1 North America Insulin Like Growth Factor 1 Receptor Forecast 2019-2025
        • 9.2.2 Europe Insulin Like Growth Factor 1 Receptor Forecast 2019-2025
        • 9.2.3 China Insulin Like Growth Factor 1 Receptor Forecast 2019-2025
        • 9.2.4 Japan Insulin Like Growth Factor 1 Receptor Forecast 2019-2025
        • 9.2.5 Southeast Asia Insulin Like Growth Factor 1 Receptor Forecast 2019-2025
        • 9.2.6 India Insulin Like Growth Factor 1 Receptor Forecast 2019-2025
      • 9.3 Insulin Like Growth Factor 1 Receptor Market Trend (Product Type)
      • 9.4 Insulin Like Growth Factor 1 Receptor Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Insulin Like Growth Factor 1 Receptor Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        The global Insulin Like Growth Factor 1 Receptor market was valued at million US$ in 2018 and will reach million US$ by the end of 2025, growing at a CAGR of during 2019-2025.
        This report focuses on Insulin Like Growth Factor 1 Receptor volume and value at global level, regional level and company level. From a global perspective, this report represents overall Insulin Like Growth Factor 1 Receptor market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Insulin Like Growth Factor 1 Receptor in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Insulin Like Growth Factor 1 Receptor manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Astellas Pharma Inc.
        AstraZeneca Plc
        Axelar AB
        Boehringer Ingelheim GmbH
        Bristol-Myers Squibb Company
        Eli Lilly and Company
        F. Hoffmann-La Roche Ltd.
        Genmab A/S
        Immunomedics, Inc.
        Insmed Incorporated
        Merck & Co., Inc.
        Merrimack Pharmaceuticals, Inc.
        Novartis AG
        PharmAbcine, Inc.
        ProteoThera, Inc.

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        BI-893923
        CT-707
        1R-E1
        ATL-1101
        Others

        Segment by Application
        Hospital
        Clinic
        Others

        Buy now